Global and United States Venous Thromboembolism (VTE) Devices Market Report & Forecast 2024-2031

Report ID: 1829645 | Published Date: Sep 2024 | No. of Page: 112 | Base Year: 2023 | Rating: 4.8 | Webstory: Check our Web story
1 Study Coverage
    1.1 Venous Thromboembolism (VTE) Devices Product Introduction
    1.2 Global Venous Thromboembolism (VTE) Devices Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Venous Thromboembolism (VTE) Devices Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Venous Thromboembolism (VTE) Devices Sales in Volume for the Year 2017-2028
    1.3 United States Venous Thromboembolism (VTE) Devices Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Venous Thromboembolism (VTE) Devices Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Venous Thromboembolism (VTE) Devices Sales in Volume for the Year 2017-2028
    1.4 Venous Thromboembolism (VTE) Devices Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Venous Thromboembolism (VTE) Devices in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Venous Thromboembolism (VTE) Devices Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Venous Thromboembolism (VTE) Devices Market Dynamics
        1.5.1 Venous Thromboembolism (VTE) Devices Industry Trends
        1.5.2 Venous Thromboembolism (VTE) Devices Market Drivers
        1.5.3 Venous Thromboembolism (VTE) Devices Market Challenges
        1.5.4 Venous Thromboembolism (VTE) Devices Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
2 Market by Type
    2.1 Venous Thromboembolism (VTE) Devices Market Segment by Type
        2.1.1 Deep Vein Thrombosis(DVT)
        2.1.2 Pulmonary Embolism(PE)
        2.1.3 Others
    2.2 Global Venous Thromboembolism (VTE) Devices Market Size by Type
        2.2.1 Global Venous Thromboembolism (VTE) Devices Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Venous Thromboembolism (VTE) Devices Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Venous Thromboembolism (VTE) Devices Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Venous Thromboembolism (VTE) Devices Market Size by Type
        2.3.1 United States Venous Thromboembolism (VTE) Devices Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Venous Thromboembolism (VTE) Devices Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Venous Thromboembolism (VTE) Devices Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
    3.1 Venous Thromboembolism (VTE) Devices Market Segment by Application
        3.1.1 Hospitals
        3.1.2 Surgical Centers
        3.1.3 Other
    3.2 Global Venous Thromboembolism (VTE) Devices Market Size by Application
        3.2.1 Global Venous Thromboembolism (VTE) Devices Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Venous Thromboembolism (VTE) Devices Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Venous Thromboembolism (VTE) Devices Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Venous Thromboembolism (VTE) Devices Market Size by Application
        3.3.1 United States Venous Thromboembolism (VTE) Devices Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Venous Thromboembolism (VTE) Devices Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Venous Thromboembolism (VTE) Devices Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Venous Thromboembolism (VTE) Devices Competitor Landscape by Company
    4.1 Global Venous Thromboembolism (VTE) Devices Market Size by Company
        4.1.1 Top Global Venous Thromboembolism (VTE) Devices Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Venous Thromboembolism (VTE) Devices Revenue by Manufacturer (2017-2022)
        4.1.3 Global Venous Thromboembolism (VTE) Devices Sales by Manufacturer (2017-2022)
        4.1.4 Global Venous Thromboembolism (VTE) Devices Price by Manufacturer (2017-2022)
    4.2 Global Venous Thromboembolism (VTE) Devices Concentration Ratio (CR)
        4.2.1 Venous Thromboembolism (VTE) Devices Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Venous Thromboembolism (VTE) Devices in 2021
        4.2.3 Global Venous Thromboembolism (VTE) Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Venous Thromboembolism (VTE) Devices Manufacturing Base Distribution, Product Type
        4.3.1 Global Venous Thromboembolism (VTE) Devices Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Venous Thromboembolism (VTE) Devices Product Type
        4.3.3 Date of International Manufacturers Enter into Venous Thromboembolism (VTE) Devices Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Venous Thromboembolism (VTE) Devices Market Size by Company
        4.5.1 Top Venous Thromboembolism (VTE) Devices Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Venous Thromboembolism (VTE) Devices Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Venous Thromboembolism (VTE) Devices Sales by Players (2020, 2021 & 2022)
5 Global Venous Thromboembolism (VTE) Devices Market Size by Region
    5.1 Global Venous Thromboembolism (VTE) Devices Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Venous Thromboembolism (VTE) Devices Market Size in Volume by Region (2017-2028)
        5.2.1 Global Venous Thromboembolism (VTE) Devices Sales in Volume by Region: 2017-2022
        5.2.2 Global Venous Thromboembolism (VTE) Devices Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Venous Thromboembolism (VTE) Devices Market Size in Value by Region (2017-2028)
        5.3.1 Global Venous Thromboembolism (VTE) Devices Sales in Value by Region: 2017-2022
        5.3.2 Global Venous Thromboembolism (VTE) Devices Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Venous Thromboembolism (VTE) Devices Market Size YoY Growth 2017-2028
        6.1.2 North America Venous Thromboembolism (VTE) Devices Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Venous Thromboembolism (VTE) Devices Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Venous Thromboembolism (VTE) Devices Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Venous Thromboembolism (VTE) Devices Market Size YoY Growth 2017-2028
        6.3.2 Europe Venous Thromboembolism (VTE) Devices Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Venous Thromboembolism (VTE) Devices Market Size YoY Growth 2017-2028
        6.4.2 Latin America Venous Thromboembolism (VTE) Devices Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Venous Thromboembolism (VTE) Devices Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Venous Thromboembolism (VTE) Devices Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE
7 Company Profiles
    7.1 ArjoHuntleigh
        7.1.1 ArjoHuntleigh Corporation Information
        7.1.2 ArjoHuntleigh Description and Business Overview
        7.1.3 ArjoHuntleigh Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 ArjoHuntleigh Venous Thromboembolism (VTE) Devices Products Offered
        7.1.5 ArjoHuntleigh Recent Development
    7.2 Armetheon
        7.2.1 Armetheon Corporation Information
        7.2.2 Armetheon Description and Business Overview
        7.2.3 Armetheon Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Armetheon Venous Thromboembolism (VTE) Devices Products Offered
        7.2.5 Armetheon Recent Development
    7.3 Bayer
        7.3.1 Bayer Corporation Information
        7.3.2 Bayer Description and Business Overview
        7.3.3 Bayer Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Bayer Venous Thromboembolism (VTE) Devices Products Offered
        7.3.5 Bayer Recent Development
    7.4 Bio Compression Systems
        7.4.1 Bio Compression Systems Corporation Information
        7.4.2 Bio Compression Systems Description and Business Overview
        7.4.3 Bio Compression Systems Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 Bio Compression Systems Venous Thromboembolism (VTE) Devices Products Offered
        7.4.5 Bio Compression Systems Recent Development
    7.5 Boehringer Ingelheim
        7.5.1 Boehringer Ingelheim Corporation Information
        7.5.2 Boehringer Ingelheim Description and Business Overview
        7.5.3 Boehringer Ingelheim Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 Boehringer Ingelheim Venous Thromboembolism (VTE) Devices Products Offered
        7.5.5 Boehringer Ingelheim Recent Development
    7.6 Breg
        7.6.1 Breg Corporation Information
        7.6.2 Breg Description and Business Overview
        7.6.3 Breg Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2017-2022)
        7.6.4 Breg Venous Thromboembolism (VTE) Devices Products Offered
        7.6.5 Breg Recent Development
    7.7 Bristol-Myers Squibb
        7.7.1 Bristol-Myers Squibb Corporation Information
        7.7.2 Bristol-Myers Squibb Description and Business Overview
        7.7.3 Bristol-Myers Squibb Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2017-2022)
        7.7.4 Bristol-Myers Squibb Venous Thromboembolism (VTE) Devices Products Offered
        7.7.5 Bristol-Myers Squibb Recent Development
    7.8 Cardinal Health
        7.8.1 Cardinal Health Corporation Information
        7.8.2 Cardinal Health Description and Business Overview
        7.8.3 Cardinal Health Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2017-2022)
        7.8.4 Cardinal Health Venous Thromboembolism (VTE) Devices Products Offered
        7.8.5 Cardinal Health Recent Development
    7.9 Currie Medical Specialties
        7.9.1 Currie Medical Specialties Corporation Information
        7.9.2 Currie Medical Specialties Description and Business Overview
        7.9.3 Currie Medical Specialties Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2017-2022)
        7.9.4 Currie Medical Specialties Venous Thromboembolism (VTE) Devices Products Offered
        7.9.5 Currie Medical Specialties Recent Development
    7.10 Daiichi-Sankyo
        7.10.1 Daiichi-Sankyo Corporation Information
        7.10.2 Daiichi-Sankyo Description and Business Overview
        7.10.3 Daiichi-Sankyo Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2017-2022)
        7.10.4 Daiichi-Sankyo Venous Thromboembolism (VTE) Devices Products Offered
        7.10.5 Daiichi-Sankyo Recent Development
    7.11 Devon Medical Products
        7.11.1 Devon Medical Products Corporation Information
        7.11.2 Devon Medical Products Description and Business Overview
        7.11.3 Devon Medical Products Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2017-2022)
        7.11.4 Devon Medical Products Venous Thromboembolism (VTE) Devices Products Offered
        7.11.5 Devon Medical Products Recent Development
    7.12 DJO
        7.12.1 DJO Corporation Information
        7.12.2 DJO Description and Business Overview
        7.12.3 DJO Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2017-2022)
        7.12.4 DJO Products Offered
        7.12.5 DJO Recent Development
    7.13 Janssen
        7.13.1 Janssen Corporation Information
        7.13.2 Janssen Description and Business Overview
        7.13.3 Janssen Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2017-2022)
        7.13.4 Janssen Products Offered
        7.13.5 Janssen Recent Development
    7.14 Mego Afek AC LTD
        7.14.1 Mego Afek AC LTD Corporation Information
        7.14.2 Mego Afek AC LTD Description and Business Overview
        7.14.3 Mego Afek AC LTD Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2017-2022)
        7.14.4 Mego Afek AC LTD Products Offered
        7.14.5 Mego Afek AC LTD Recent Development
    7.15 Normatec
        7.15.1 Normatec Corporation Information
        7.15.2 Normatec Description and Business Overview
        7.15.3 Normatec Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2017-2022)
        7.15.4 Normatec Products Offered
        7.15.5 Normatec Recent Development
    7.16 Pfizer
        7.16.1 Pfizer Corporation Information
        7.16.2 Pfizer Description and Business Overview
        7.16.3 Pfizer Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2017-2022)
        7.16.4 Pfizer Products Offered
        7.16.5 Pfizer Recent Development
    7.17 Portola Pharmaceuticals
        7.17.1 Portola Pharmaceuticals Corporation Information
        7.17.2 Portola Pharmaceuticals Description and Business Overview
        7.17.3 Portola Pharmaceuticals Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2017-2022)
        7.17.4 Portola Pharmaceuticals Products Offered
        7.17.5 Portola Pharmaceuticals Recent Development
    7.18 ThermoTek USA
        7.18.1 ThermoTek USA Corporation Information
        7.18.2 ThermoTek USA Description and Business Overview
        7.18.3 ThermoTek USA Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2017-2022)
        7.18.4 ThermoTek USA Products Offered
        7.18.5 ThermoTek USA Recent Development
    7.19 Zimmer Biomet
        7.19.1 Zimmer Biomet Corporation Information
        7.19.2 Zimmer Biomet Description and Business Overview
        7.19.3 Zimmer Biomet Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2017-2022)
        7.19.4 Zimmer Biomet Products Offered
        7.19.5 Zimmer Biomet Recent Development
8 Industry Chain and Sales Channels Analysis
    8.1 Venous Thromboembolism (VTE) Devices Industry Chain Analysis
    8.2 Venous Thromboembolism (VTE) Devices Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Venous Thromboembolism (VTE) Devices Distributors
    8.3 Venous Thromboembolism (VTE) Devices Production Mode & Process
    8.4 Venous Thromboembolism (VTE) Devices Sales and Marketing
        8.4.1 Venous Thromboembolism (VTE) Devices Sales Channels
        8.4.2 Venous Thromboembolism (VTE) Devices Distributors
    8.5 Venous Thromboembolism (VTE) Devices Customers
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer
List of Tables
    Table 1. Venous Thromboembolism (VTE) Devices CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Venous Thromboembolism (VTE) Devices Market Trends
    Table 3. Venous Thromboembolism (VTE) Devices Market Drivers
    Table 4. Venous Thromboembolism (VTE) Devices Market Challenges
    Table 5. Venous Thromboembolism (VTE) Devices Market Restraints
    Table 6. Global Venous Thromboembolism (VTE) Devices Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Venous Thromboembolism (VTE) Devices Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Venous Thromboembolism (VTE) Devices Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Venous Thromboembolism (VTE) Devices Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Venous Thromboembolism (VTE) Devices Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Venous Thromboembolism (VTE) Devices Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Venous Thromboembolism (VTE) Devices Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Venous Thromboembolism (VTE) Devices Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Venous Thromboembolism (VTE) Devices Sales Share by Manufacturer, 2017-2022
    Table 15. Global Venous Thromboembolism (VTE) Devices Price by Manufacturer (2017-2022) & (US$/Unit)
    Table 16. Global Venous Thromboembolism (VTE) Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Venous Thromboembolism (VTE) Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Venous Thromboembolism (VTE) Devices as of 2021)
    Table 18. Top Players of Venous Thromboembolism (VTE) Devices in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Venous Thromboembolism (VTE) Devices Product Type
    Table 20. Date of International Manufacturers Enter into Venous Thromboembolism (VTE) Devices Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Venous Thromboembolism (VTE) Devices Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Venous Thromboembolism (VTE) Devices Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Venous Thromboembolism (VTE) Devices Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Venous Thromboembolism (VTE) Devices Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Venous Thromboembolism (VTE) Devices Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Venous Thromboembolism (VTE) Devices Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Venous Thromboembolism (VTE) Devices Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Venous Thromboembolism (VTE) Devices Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Venous Thromboembolism (VTE) Devices Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Venous Thromboembolism (VTE) Devices Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Venous Thromboembolism (VTE) Devices Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Venous Thromboembolism (VTE) Devices Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Venous Thromboembolism (VTE) Devices Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Venous Thromboembolism (VTE) Devices Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Venous Thromboembolism (VTE) Devices Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Venous Thromboembolism (VTE) Devices Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Venous Thromboembolism (VTE) Devices Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Venous Thromboembolism (VTE) Devices Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Venous Thromboembolism (VTE) Devices Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Venous Thromboembolism (VTE) Devices Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. ArjoHuntleigh Corporation Information
    Table 43. ArjoHuntleigh Description and Business Overview
    Table 44. ArjoHuntleigh Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 45. ArjoHuntleigh Venous Thromboembolism (VTE) Devices Product
    Table 46. ArjoHuntleigh Recent Development
    Table 47. Armetheon Corporation Information
    Table 48. Armetheon Description and Business Overview
    Table 49. Armetheon Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 50. Armetheon Product
    Table 51. Armetheon Recent Development
    Table 52. Bayer Corporation Information
    Table 53. Bayer Description and Business Overview
    Table 54. Bayer Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 55. Bayer Product
    Table 56. Bayer Recent Development
    Table 57. Bio Compression Systems Corporation Information
    Table 58. Bio Compression Systems Description and Business Overview
    Table 59. Bio Compression Systems Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 60. Bio Compression Systems Product
    Table 61. Bio Compression Systems Recent Development
    Table 62. Boehringer Ingelheim Corporation Information
    Table 63. Boehringer Ingelheim Description and Business Overview
    Table 64. Boehringer Ingelheim Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 65. Boehringer Ingelheim Product
    Table 66. Boehringer Ingelheim Recent Development
    Table 67. Breg Corporation Information
    Table 68. Breg Description and Business Overview
    Table 69. Breg Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 70. Breg Product
    Table 71. Breg Recent Development
    Table 72. Bristol-Myers Squibb Corporation Information
    Table 73. Bristol-Myers Squibb Description and Business Overview
    Table 74. Bristol-Myers Squibb Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 75. Bristol-Myers Squibb Product
    Table 76. Bristol-Myers Squibb Recent Development
    Table 77. Cardinal Health Corporation Information
    Table 78. Cardinal Health Description and Business Overview
    Table 79. Cardinal Health Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 80. Cardinal Health Product
    Table 81. Cardinal Health Recent Development
    Table 82. Currie Medical Specialties Corporation Information
    Table 83. Currie Medical Specialties Description and Business Overview
    Table 84. Currie Medical Specialties Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 85. Currie Medical Specialties Product
    Table 86. Currie Medical Specialties Recent Development
    Table 87. Daiichi-Sankyo Corporation Information
    Table 88. Daiichi-Sankyo Description and Business Overview
    Table 89. Daiichi-Sankyo Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 90. Daiichi-Sankyo Product
    Table 91. Daiichi-Sankyo Recent Development
    Table 92. Devon Medical Products Corporation Information
    Table 93. Devon Medical Products Description and Business Overview
    Table 94. Devon Medical Products Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 95. Devon Medical Products Product
    Table 96. Devon Medical Products Recent Development
    Table 97. DJO Corporation Information
    Table 98. DJO Description and Business Overview
    Table 99. DJO Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 100. DJO Product
    Table 101. DJO Recent Development
    Table 102. Janssen Corporation Information
    Table 103. Janssen Description and Business Overview
    Table 104. Janssen Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 105. Janssen Product
    Table 106. Janssen Recent Development
    Table 107. Mego Afek AC LTD Corporation Information
    Table 108. Mego Afek AC LTD Description and Business Overview
    Table 109. Mego Afek AC LTD Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 110. Mego Afek AC LTD Product
    Table 111. Mego Afek AC LTD Recent Development
    Table 112. Normatec Corporation Information
    Table 113. Normatec Description and Business Overview
    Table 114. Normatec Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 115. Normatec Product
    Table 116. Normatec Recent Development
    Table 117. Pfizer Corporation Information
    Table 118. Pfizer Description and Business Overview
    Table 119. Pfizer Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 120. Pfizer Product
    Table 121. Pfizer Recent Development
    Table 122. Portola Pharmaceuticals Corporation Information
    Table 123. Portola Pharmaceuticals Description and Business Overview
    Table 124. Portola Pharmaceuticals Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 125. Portola Pharmaceuticals Product
    Table 126. Portola Pharmaceuticals Recent Development
    Table 127. ThermoTek USA Corporation Information
    Table 128. ThermoTek USA Description and Business Overview
    Table 129. ThermoTek USA Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 130. ThermoTek USA Product
    Table 131. ThermoTek USA Recent Development
    Table 132. Zimmer Biomet Corporation Information
    Table 133. Zimmer Biomet Description and Business Overview
    Table 134. Zimmer Biomet Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 135. Zimmer Biomet Product
    Table 136. Zimmer Biomet Recent Development
    Table 137. Key Raw Materials Lists
    Table 138. Raw Materials Key Suppliers Lists
    Table 139. Venous Thromboembolism (VTE) Devices Customers List
    Table 140. Venous Thromboembolism (VTE) Devices Distributors List
    Table 141. Research Programs/Design for This Report
    Table 142. Key Data Information from Secondary Sources
    Table 143. Key Data Information from Primary Sources
List of Figures
    Figure 1. Venous Thromboembolism (VTE) Devices Product Picture
    Figure 2. Global Venous Thromboembolism (VTE) Devices Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Venous Thromboembolism (VTE) Devices Market Size 2017-2028 (US$ Million)
    Figure 4. Global Venous Thromboembolism (VTE) Devices Sales 2017-2028 (K Units)
    Figure 5. United States Venous Thromboembolism (VTE) Devices Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Venous Thromboembolism (VTE) Devices Market Size 2017-2028 (US$ Million)
    Figure 7. United States Venous Thromboembolism (VTE) Devices Sales 2017-2028 (K Units)
    Figure 8. United States Venous Thromboembolism (VTE) Devices Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Venous Thromboembolism (VTE) Devices Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Venous Thromboembolism (VTE) Devices Report Years Considered
    Figure 11. Product Picture of Deep Vein Thrombosis(DVT)
    Figure 12. Product Picture of Pulmonary Embolism(PE)
    Figure 13. Product Picture of Others
    Figure 14. Global Venous Thromboembolism (VTE) Devices Market Share by Type in 2022 & 2028
    Figure 15. Global Venous Thromboembolism (VTE) Devices Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 16. Global Venous Thromboembolism (VTE) Devices Sales Market Share in Value by Type (2017-2028)
    Figure 17. Global Venous Thromboembolism (VTE) Devices Sales by Type (2017-2028) & (K Units)
    Figure 18. Global Venous Thromboembolism (VTE) Devices Sales Market Share in Volume by Type (2017-2028)
    Figure 19. Global Venous Thromboembolism (VTE) Devices Price by Type (2017-2028) & (US$/Unit)
    Figure 20. United States Venous Thromboembolism (VTE) Devices Market Share by Type in 2022 & 2028
    Figure 21. United States Venous Thromboembolism (VTE) Devices Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 22. United States Venous Thromboembolism (VTE) Devices Sales Market Share in Value by Type (2017-2028)
    Figure 23. United States Venous Thromboembolism (VTE) Devices Sales by Type (2017-2028) & (K Units)
    Figure 24. United States Venous Thromboembolism (VTE) Devices Sales Market Share in Volume by Type (2017-2028)
    Figure 25. United States Venous Thromboembolism (VTE) Devices Price by Type (2017-2028) & (US$/Unit)
    Figure 26. Product Picture of Hospitals
    Figure 27. Product Picture of Surgical Centers
    Figure 28. Product Picture of Other
    Figure 29. Global Venous Thromboembolism (VTE) Devices Market Share by Application in 2022 & 2028
    Figure 30. Global Venous Thromboembolism (VTE) Devices Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 31. Global Venous Thromboembolism (VTE) Devices Sales Market Share in Value by Application (2017-2028)
    Figure 32. Global Venous Thromboembolism (VTE) Devices Sales by Application (2017-2028) & (K Units)
    Figure 33. Global Venous Thromboembolism (VTE) Devices Sales Market Share in Volume by Application (2017-2028)
    Figure 34. Global Venous Thromboembolism (VTE) Devices Price by Application (2017-2028) & (US$/Unit)
    Figure 35. United States Venous Thromboembolism (VTE) Devices Market Share by Application in 2022 & 2028
    Figure 36. United States Venous Thromboembolism (VTE) Devices Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 37. United States Venous Thromboembolism (VTE) Devices Sales Market Share in Value by Application (2017-2028)
    Figure 38. United States Venous Thromboembolism (VTE) Devices Sales by Application (2017-2028) & (K Units)
    Figure 39. United States Venous Thromboembolism (VTE) Devices Sales Market Share in Volume by Application (2017-2028)
    Figure 40. United States Venous Thromboembolism (VTE) Devices Price by Application (2017-2028) & (US$/Unit)
    Figure 41. North America Venous Thromboembolism (VTE) Devices Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 42. North America Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 43. U.S. Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Canada Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Europe Venous Thromboembolism (VTE) Devices Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 46. Europe Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. Germany Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. France Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. U.K. Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Italy Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Russia Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Asia-Pacific Venous Thromboembolism (VTE) Devices Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 53. Asia-Pacific Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 54. China Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Japan Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. South Korea Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. India Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Australia Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Taiwan Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Indonesia Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Thailand Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Malaysia Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Philippines Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Latin America Venous Thromboembolism (VTE) Devices Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 65. Latin America Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 66. Mexico Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Brazil Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Argentina Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Middle East & Africa Venous Thromboembolism (VTE) Devices Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 70. Middle East & Africa Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 71. Turkey Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Saudi Arabia Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. UAE Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Venous Thromboembolism (VTE) Devices Value Chain
    Figure 75. Venous Thromboembolism (VTE) Devices Production Process
    Figure 76. Channels of Distribution
    Figure 77. Distributors Profiles
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
ArjoHuntleigh
Armetheon
Bayer
Bio Compression Systems
Boehringer Ingelheim
Breg
Bristol-Myers Squibb
Cardinal Health
Currie Medical Specialties
Daiichi-Sankyo
Devon Medical Products
DJO
Janssen
Mego Afek AC LTD
Normatec
Pfizer
Portola Pharmaceuticals
ThermoTek USA
Zimmer Biomet
Frequently Asked Questions
Venous Thromboembolism (VTE) Devices report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Venous Thromboembolism (VTE) Devices report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Venous Thromboembolism (VTE) Devices report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports